BioPharma Credit PLC (BPCR) — Net Asset Momentum
BioPharma Credit PLC (BPCR) recorded a net asset momentum of -11.9% as of December 2024, with net assets of $1.18 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is BioPharma Credit PLC's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
BioPharma Credit PLC Net Asset Momentum (2017–2024)
This chart tracks BioPharma Credit PLC's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -11.9%, with net assets of $1.18 Billion USD as of December 2024. Check how tangible is BioPharma Credit PLC's equity to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for BioPharma Credit PLC (2017–2024)
The table below shows the complete annual net asset history for BioPharma Credit PLC from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see BPCR company net worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $1.18 Billion | $1.20 Billion | $17.94 Million | ▼ -11.9% |
| 2023 | $1.34 Billion | $1.36 Billion | $15.87 Million | ▲ +0.2% |
| 2022 | $1.34 Billion | $1.36 Billion | $26.30 Million | ▼ -1.9% |
| 2021 | $1.36 Billion | $1.37 Billion | $6.90 Million | ▼ -1.1% |
| 2020 | $1.38 Billion | $1.39 Billion | $9.39 Million | ▼ -1.8% |
| 2019 | $1.40 Billion | $1.43 Billion | $25.23 Million | ▲ +1.7% |
| 2018 | $1.38 Billion | $1.39 Billion | $13.25 Million | ▲ +49.6% |
| 2017 | $922.57 Million | $925.49 Million | $2.92 Million | — |